Simcere Pharmaceutical Group (NYSE:SCR)

CAPS Rating: 4 out of 5

The Company is a manufacturer and supplier of branded generic pharmaceuticals in the fast growing China market.

Recs

0
Player Avatar Boone12 (< 20) Submitted: 6/3/2008 12:15:14 PM : Outperform Start Price: $14.40 SCR Score: -39.06

With the price of the stocks for this company there is still intrest in what it can do for the country.

Featured Broker Partners


Advertisement